76 related articles for article (PubMed ID: 21958730)
1. Mutations in long-lived epithelial stem cells and their clonal progeny in pre-malignant lesions and in oral squamous cell carcinoma.
Melis M; Zhang T; Scognamiglio T; Gudas LJ
Carcinogenesis; 2020 Nov; 41(11):1553-1564. PubMed ID: 32115621
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 33 supports squamous cell carcinoma growth via a dual effect on tumour proliferation, migration and invasion, and T cell activation.
Perri G; Vilas Boas VG; Nogueira MRS; Mello Júnior EJF; Coelho AL; Posadas EM; Hogaboam C; Cavassani KA; Campanelli AP
Cancer Immunol Immunother; 2024 Apr; 73(6):110. PubMed ID: 38662248
[TBL] [Abstract][Full Text] [Related]
3. Pleckstrin Homology Domain Leucine-rich Repeat Protein Phosphatase Acts as a Tumor Suppressor in Oral Squamous Cell Carcinoma.
Etemad-Moghadam S; Mohammadpour H; Emami Razavi A; Alaeddini M
Appl Immunohistochem Mol Morphol; 2024 May-Jun 01; 32(5):249-253. PubMed ID: 38602289
[TBL] [Abstract][Full Text] [Related]
4. Editorial Note: Cutaneous Squamous Cell Carcinoma (SCC) and the DNA Damage Response: pATM Expression Patterns in Pre-Malignant and Malignant Keratinocyte Skin Lesions.
PLOS ONE Editors
PLoS One; 2024; 19(5):e0303120. PubMed ID: 38696417
[No Abstract] [Full Text] [Related]
5. A non-toxic, reversibly released imaging probe for oral cancer that is derived from natural compounds.
Ghanim M; Relitti N; McManus G; Butini S; Cappelli A; Campiani G; Mok KH; Kelly VP
Sci Rep; 2021 Jul; 11(1):14069. PubMed ID: 34234213
[TBL] [Abstract][Full Text] [Related]
6. Enhanced metastatic potential in the MB49 urothelial carcinoma model.
Liu YR; Yin PN; Silvers CR; Lee YF
Sci Rep; 2019 May; 9(1):7425. PubMed ID: 31092844
[TBL] [Abstract][Full Text] [Related]
7. Deregulation of decorin and FHL1 are associated with esophageal squamous cell carcinoma progression and poor prognosis.
Ji C; Liu H; Xiang M; Liu J; Yue F; Wang W; Chu X
Int J Clin Exp Med; 2015; 8(11):20965-70. PubMed ID: 26885026
[TBL] [Abstract][Full Text] [Related]
8. Microenvironmental Modulation of Decorin and Lumican in Temozolomide-Resistant Glioblastoma and Neuroblastoma Cancer Stem-Like Cells.
Farace C; Oliver JA; Melguizo C; Alvarez P; Bandiera P; Rama AR; Malaguarnera G; Ortiz R; Madeddu R; Prados J
PLoS One; 2015; 10(7):e0134111. PubMed ID: 26230845
[TBL] [Abstract][Full Text] [Related]
9. Decorin is responsible for progression of non-small-cell lung cancer by promoting cell proliferation and metastasis.
Shi X; Liang W; Yang W; Xia R; Song Y
Tumour Biol; 2015 May; 36(5):3345-54. PubMed ID: 25524578
[TBL] [Abstract][Full Text] [Related]
10. Opticin, a small leucine-rich proteoglycan, is uniquely expressed and translocated to the nucleus of chronic lymphocytic leukemia cells.
Mikaelsson E; Osterborg A; Tahmasebi Fard Z; Mahmoudi A; Mahmoudian J; Jeddi-Tehrani M; Akhondi M; Shokri F; Bishop PN; Rabbani H; Mellstedt H
Exp Hematol Oncol; 2013 Aug; 2(1):23. PubMed ID: 24499526
[TBL] [Abstract][Full Text] [Related]
11. An essential role for decorin in bladder cancer invasiveness.
El Behi M; Krumeich S; Lodillinsky C; Kamoun A; Tibaldi L; Sugano G; De Reynies A; Chapeaublanc E; Laplanche A; Lebret T; Allory Y; Radvanyi F; Lantz O; Eiján AM; Bernard-Pierrot I; Théry C
EMBO Mol Med; 2013 Dec; 5(12):1835-51. PubMed ID: 24142880
[TBL] [Abstract][Full Text] [Related]
12. A role for aberrantly expressed nuclear localized decorin in migration and invasion of dysplastic and malignant oral epithelial cells.
Dil N; Banerjee AG
Head Neck Oncol; 2011 Sep; 3():44. PubMed ID: 21958730
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of aberrantly expressed nuclear localized decorin attenuates tumour angiogenesis related mediators in oral cancer progression model in vitro.
Dil N; Banerjee AG
Head Neck Oncol; 2012 Jun; 4():11. PubMed ID: 22507529
[TBL] [Abstract][Full Text] [Related]
14. Aberrant expression and localization of decorin in human oral dysplasia and squamous cell carcinoma.
Banerjee AG; Bhattacharyya I; Lydiatt WM; Vishwanatha JK
Cancer Res; 2003 Nov; 63(22):7769-76. PubMed ID: 14633702
[TBL] [Abstract][Full Text] [Related]
15. EMMPRIN/CD147 up-regulates urokinase-type plasminogen activator: implications in oral tumor progression.
Lescaille G; Menashi S; Cavelier-Balloy B; Khayati F; Quemener C; Podgorniak MP; Naïmi B; Calvo F; Lebbe C; Mourah S
BMC Cancer; 2012 Mar; 12():115. PubMed ID: 22443116
[TBL] [Abstract][Full Text] [Related]
16. MIEN1 promotes oral cancer progression and implicates poor overall survival.
Rajendiran S; Kpetemey M; Maji S; Gibbs LD; Dasgupta S; Mantsch R; Hare RJ; Vishwanatha JK
Cancer Biol Ther; 2015; 16(6):876-85. PubMed ID: 25996585
[TBL] [Abstract][Full Text] [Related]
17. Cytokines secreted by inflamed oral mucosa: implications for oral cancer progression.
Danella EB; Costa de Medeiros M; D'Silva NJ
Oncogene; 2023 Apr; 42(15):1159-1165. PubMed ID: 36879116
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
